Related references
Note: Only part of the references are listed.RecurrenceOnline: an online analysis tool to determine breast cancer recurrence and hormone receptor status using microarray data
Balazs Gyorffy et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Cancer Statistics, 2012
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2012)
Enhancer of zeste homolog 2 is a novel prognostic biomarker in nonsmall cell lung cancer
Huqun et al.
CANCER (2012)
Prognostic value of matrix metalloproteinase 9 expression in patients with non-small cell lung cancer
Wen-Jia Peng et al.
CLINICA CHIMICA ACTA (2012)
Meta-analysis for cyclin E in lung cancer survival
Li-nian Huang et al.
CLINICA CHIMICA ACTA (2012)
The Role of Cyclin D1 Expression and Patient's Survival in Non-Small-Cell Lung Cancer: A Systematic Review With Meta-Analysis
Lou Qian Zhang et al.
CLINICAL LUNG CANCER (2012)
Comprehensive genomic characterization of squamous cell lung cancers
Peter S. Hammerman et al.
NATURE (2012)
Interferon (Alpha, Beta and Omega) Receptor 2 Is a Prognostic Biomarker for Lung Cancer
Sonosuke Tanaka et al.
PATHOBIOLOGY (2012)
Prognostic Value of Survivin in Patients with Non-Small Cell Lung Carcinoma: A Systematic Review with Meta-Analysis
Lou Qian Zhang et al.
PLOS ONE (2012)
Epidermal Growth Factor Receptor Tyrosine Kinase Defines Critical Prognostic Genes of Stage I Lung Adenocarcinoma
Mai Yamauchi et al.
PLOS ONE (2012)
Lung Cancer: New Biological Insights and Recent Therapeutic Advances
Suresh S. Ramalingam et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Robust Gene Expression Signature from Formalin-Fixed Paraffin-Embedded Samples Predicts Prognosis of Non-Small-Cell Lung Cancer Patients
Yang Xie et al.
CLINICAL CANCER RESEARCH (2011)
ADAM28 is a serological and histochemical marker for non-small-cell lung cancers
Hiroaki Kuroda et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Prognosis of Women With Metastatic Breast Cancer by HER2 Status and Trastuzumab Treatment: An Institutional-Based Review
Shaheenah Dawood et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Prognostic and Predictive Gene Signature for Adjuvant Chemotherapy in Resected Non-Small-Cell Lung Cancer
Chang-Qi Zhu et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
CD24, a Novel Cancer Biomarker, Predicting Disease-Free Survival of Non-small Cell Lung Carcinomas A Retrospective Study of Prognostic Factor Analysis from the Viewpoint of Forthcoming (Seventh) New TNM Classification
Hyun Ju Lee et al.
JOURNAL OF THORACIC ONCOLOGY (2010)
Gene Expression-Based Classification of Non-Small Cell Lung Carcinomas and Survival Prediction
Jun Hou et al.
PLOS ONE (2010)
Quantitative proteome analysis reveals annexin A3 as a novel biomarker in lung adenocarcinoma
Y. F. Liu et al.
JOURNAL OF PATHOLOGY (2009)
Prognostic Value of Vascular Endothelial Growth Factor Expression in Patients with Lung Cancer A Systematic Review with Meta-Analysis
Ping Zhan et al.
JOURNAL OF THORACIC ONCOLOGY (2009)
Evaluation of Microarray Preprocessing Algorithms Based on Concordance with RT-PCR in Clinical Samples
Balazs Gyorffy et al.
PLOS ONE (2009)
Prediction of Recurrence-Free Survival in Postoperative Non-Small Cell Lung Cancer Patients by Using an Integrated Model of Clinical Information and Gene Expression
Eung-Sirk Lee et al.
CLINICAL CANCER RESEARCH (2008)
Lung Adjuvant Cisplatin Evaluation: A pooled analysis by the LACE collaborative group
Jean-Pierre Pignon et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Gene expression-based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study
Kerby Shedden et al.
NATURE MEDICINE (2008)
A phase I study with exploratory pharmacodynamic endpoints of XL647, a novel spectrum selective kinase inhibitor, administered orally daily to patients (pts) with advanced solid malignancies
H. A. Wakelee et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Lung cancer incidence in never smokers
Heather A. Wakelee et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
A gene expression signature predicts survival of patients with stage I non-small cell lung cancer
Yan Lu et al.
PLOS MEDICINE (2006)
Gene expression profiling reveals reproducible human lung adenocarcinoma subtypes in multiple independent patient cohorts
D. Neil Hayes et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Gene expression signatures for predicting prognosis of squamous cell and adenocarcinomas of the lung
Mitch Raponi et al.
CANCER RESEARCH (2006)
Constructing molecular classifiers for the accurate prognosis of lung adenocarcinoma
Lan Guo et al.
CLINICAL CANCER RESEARCH (2006)
Oncogenic pathway signatures in human cancers as a guide to targeted therapies
AH Bild et al.
NATURE (2006)
High-level expression of Rad51 is an independent prognostic marker of survival in non-small-cell lung cancer patients
GB Qiao et al.
BRITISH JOURNAL OF CANCER (2005)
Prediction of lymph node metastasis by analysis of gene expression profiles in primary lung adenocarcinomas
LQ Xi et al.
CLINICAL CANCER RESEARCH (2005)
ERCC1 expression is a predictor of survival in resected patients with non-small cell lung cancer
GR Simon et al.
CHEST (2005)
Osteopontin but not osteonectin messenger RNA expression is a prognostic marker in curatively resected non-small cell lung cancer
S Schneider et al.
CLINICAL CANCER RESEARCH (2004)
Prognostic factors in resected stage I non-small-cell lung cancer: A multivariate analysis of six molecular markers
C Lu et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses
A Bhattacharjee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Cyclin D1, p16 and retinoblastoma gene product expression as a predictor for prognosis in non-small cell lung cancer at stages I and II
ML Jin et al.
LUNG CANCER (2001)
Funnel plots for detecting bias in meta-analysis: Guidelines on choice of axis
JAC Sterne et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2001)
Share Paper
